Hela Difluo Invivogen
Lab Reagents
Human IgG antibody Laboratories manufactures the hela difluo invivogen reagents distributed by Genprice. The Hela Difluo Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Hela products are available in stock. Specificity: Hela Category: Difluo Group: Invivogen
Hela-GFP stable cells (Blasticidin) |
|||
SC034-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 930 |
Description: GFP expression stable cell line in Hela cells with Blasticidin marker. |
Hela-GFP stable cells (Puromycin) |
|||
SC034-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 930 |
Description: GFP expression stable cell line in Hela cells with Puromycin marker. |
Hela-TetR (Puro) stable cells |
|||
SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
HeLa Nuclear Extract (DTT-free) |
|||
7947-01 | Biovision | each | EUR 222 |
HeLa Nuclear Extract (DTT-free) |
|||
7947-1 | Biovision | each | EUR 379.2 |
Cas9-Expressing HeLa Cell Pool |
|||
78161 | BPS Bioscience | 2 vials | EUR 795 |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing HeLa cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. |
CRISPRa (SAM) HeLa Cell Line |
|||
78193 | BPS Bioscience | 2 vials | EUR 2500 |
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR associated protein 9), lacking any endonuclease activity, fused to transcriptional activator VP64. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag, which is maintained with Hygromycin resistance. When these cells are transfected with an MS2- tagged sgRNA targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the genomic DNA and begin transcription, inducing expression of the desired gene. |
ACE2 - HeLa Recombinant Cell Line |
|||
79958 | BPS Bioscience | 2 vials | EUR 4950 |
Description: Recombinant clonal stable HeLa cell line constitutively expressing full length human ACE2, Genbank #NM_021804.3). Surface expression of ACE2 was confirmed by flow cytometry. |
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
NHELA-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
NHELA-50 | Alpha Diagnostics | 50 ug | EUR 153.6 |
Luciferase (firefly), Hela stable cells (Blasticidin) |
|||
SC032-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
Description: Luciferase (firefry) expression stable cell line in Hela cells with Blasticidin marker. |
Luciferase (firefly), Hela stable cells (Puromycin) |
|||
SC032-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1452 |
Description: Luciferase (firefry) expression stable cell line in Hela cells with Puromycin marker. |
Inducible GFP Hela stable cell line |
|||
SC036 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1800 |
Description: InducibleGFP expression stable cell line in Hela cells, with Neomycin and puromycin resitance |
Inducible RFP Hela stable cell line |
|||
SC037 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1800 |
Description: Inducible RFP expression stable cell line in Hela with Blasticidin and Puromycin resistance |
Hela-rtTA (GFP-Bsd) stable cells |
|||
SC038-GB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1974 |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Blasticidin fusion dual marker |
Hela-rtTA (GFP-Puro) stable cells |
|||
SC038-GP | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1974 |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Puromycin fusion dual marker |
Hela-rtTA (RFP-Bsd) stable cells |
|||
SC038-RB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1974 |
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with RFP-Blasticidin fusion dual marker |